Gretchen Randlett
Executive Director of Expanded Access
Carmel, IN, USA | Eli Lilly and Company
About
Gretchen Randlett is Eli Lilly’s Expanded Access and Contiued Access Supply Stategy Senior Director. Her responsibility is to be the primary interface between clinical, medical, clinical trials organization and commercial, to support Expand Access programs and requests. As part of her role, she is responsible for designing Lilly’s infrastructure by leading cross-functional teams to develop packaging, labeling, distribution and regulatory strategies, to support these unique programs. She also consults across organizations in Lilly to deliver the appropriate supply solution to patients requesting Lilly products under the Expand Access umbrella. Gretchen has over 20 years of clinical trial experience supporting phase I-IV global trial in multiple therapeutic areas including neuroscience, men’s health, women’s health, cardiovascular, oncology, autoimmune and endocrine. In addition to her clinical knowledge, she has 6 years bioanalytical laboratory experience in developing bio assays for phase I-IV clinical trials. Her leadership experience includes supervisory roles, Six Sigma Black Belt, alliance and partner management, in addition to leading multiple cross-functional transformation projects and initiatives. Gretchen holds a Bachelor’s degree in Biology from the University of West Alabama She is the Chair of the Global Clinical Supplies Group Expanded Access Resource Committee and a member of the Managed Access Industry Forum. In her spare time she enjoys gardening, hiking, kayaking, riding horses and volunteering in her community.
Contact
| Location | Carmel, IN, USA |
| Company | Eli Lilly and Company |
| Position | Executive Director of Expanded Access |
| randlett_gretchen_m@lilly.com |
Industry Related Information
| Membership Segmentation | Pharma Biotech |
| Areas of Expertise |
Clinical Supplies Management Early Access Program |
Your Conferences
View the conferences you have attended.
